| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4006805 | Archivos de la Sociedad Española de Oftalmología | 2015 | 7 Pages |
Abstract
Patients with a genotype show increased resistance to chemotherapy should be evaluated more closely and treated with various therapeutic weapons early. Patients that have deletions in the RB1 gene are at increased risk of chemoresistance. It is likely that other genetic alterations other than RB1 gene may be related to tumor aggressiveness and treatment resistance.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
N. Ruiz del RÃo, J.M. Abelairas Gómez, F.J. Alonso GarcÃa de la Rosa, J.M. Peralta Calvo, A. de las Heras MartÃn,